For many years, drug companies have sought another large market for their drugs: senility. However, the ineffectiveness of cholesterol-lowering drugs, known as statins, in preventing Alzheimer's and other kinds of dementia has become blatantly obvious, a study by the University of Washington proven.
Researchers followed some 2,800 older patients (average age 75) with no indication of cognitive problems at baseline. The team kept track of those who developed dementia and Alzheimer's over a six-year period -- giving patients memory and cognitive skills tests along the way -- noting any statin drug use.
Data showed that patients who took statins developed dementia or Alzheimer's at virtually the same rate as those who didn't take the drugs.
Time to Face the Music
Despite the telling results, "experts" aren't ready to accept defeat just yet. In fact, they are considering mounting a larger study that compares the "benefit" of statins versus a placebo on baby boomers over a longer period.
Archives of Neurology July 2005; 62:1047-1051
USA Today July 12, 2005